Adagene Inc
NASDAQ:ADAG

Watchlist Manager
Adagene Inc Logo
Adagene Inc
NASDAQ:ADAG
Watchlist
Price: 1.82 USD 12% Market Closed
Market Cap: 85.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+466%
Revenue
Forecast
+368%
Operating Income
Forecast
-27%
Net Income
Forecast
-13%

Wall Street
Price Targets

ADAG Price Targets Summary
Adagene Inc

Wall Street analysts forecast ADAG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADAG is 10.31 USD with a low forecast of 3.54 USD and a high forecast of 19.75 USD.

ADAG Lowest Forecast
Wall Street Target
3.54 USD
94% Upside
ADAG Average Forecast
Wall Street Target
10.31 USD
466% Upside
ADAG Highest Forecast
Wall Street Target
19.75 USD
985% Upside
Lowest
Price Target
3.54 USD
94% Upside
Average
Price Target
10.31 USD
466% Upside
Highest
Price Target
19.75 USD
985% Upside
Adagene Inc Competitors:
Price Targets
UTHR
United Therapeutics Corp
30% Upside
A
ACLX
Arcellx Inc
84% Upside
ABBV
Abbvie Inc
19% Upside
F
FLUO
Fluoguide AS
162% Upside
UTHR
United Therapeutics Corp
30% Upside
A
ACLX
Arcellx Inc
84% Upside
ABBV
Abbvie Inc
19% Upside
F
FLUO
Fluoguide AS
162% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
7% Upside
6855
Ascentage Pharma Group International
8% Upside
D
688192
Dizal Jiangsu Pharmaceutical Co Ltd
27% Upside
PYC
PYC Therapeutics Ltd
190% Upside

Revenue
Forecast

Revenue Estimate
Adagene Inc

For the last 5 years the compound annual growth rate for Adagene Inc's revenue is -26%. The projected CAGR for the next 3 years is 368%.

-26%
Past Growth
368%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
ADAG intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADAG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADAG stock valuation using valuation multiples.
Wall Street Estimates
ADAG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADAG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADAG's stock price target?
Price Target
10.31 USD

According to Wall Street analysts, the average 1-year price target for ADAG is 10.31 USD with a low forecast of 3.54 USD and a high forecast of 19.75 USD.

What is Adagene Inc's Revenue forecast?
Projected CAGR
368%

For the last 5 years the compound annual growth rate for Adagene Inc's revenue is -26%. The projected CAGR for the next 3 years is 368%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.